Mitchell Berenson
CEO of IV Ensure and President of Community Infusion Solutions
Mitchell Berenson is the CEO of IV Ensure and President of Community Infusion Solutions. He also serves as Board Chair of the National Rural Oncology Collaborative and is actively involved in community-led health and servant-based mission organizations. Mitchell received his BS in Marketing from Oklahoma State University and a Master of Public Health with an emphasis in Health Policy and Epidemiology from the University of Oklahoma, Hudson School of Public Health. He completed administrative residency at Johns Hopkins Hospital in Baltimore, MD. In 2008, Mitchell founded Community Infusion Solutions to improve patient outcomes through IV therapy program development and medication adherence. Programming has served more than 420K patient visits and generates $50 million annually for rural community hospitals across 22 states. Building on this success, he founded IV Ensure in 2019 to scale these outcomes globally. IV Ensure’s IoT biotech device and care platform significantly reduces lower limb amputation rates, deaths due to chronic infections, and hospital readmissions, with clinical trial noting an 86% reduction in readmission rates for patients with chronic infections such as sepsis, urinary tract infections, and bone infections. Mitchell is a national presenter on value-based care (VBC) and rural health topics, including expanding access to comprehensive cancer care and building scalable health service lines. He also speaks on the clinical impact of remote patient monitoring and how high patient medication adherence leads to reduced poverty.